Literature DB >> 11724901

Characterization of a polyclonal antibody to human pituitary tumor transforming gene 1 (PTTG1) protein.

S S Kakar1, L Chen, R Puri, S E Flynn, L Jennes.   

Abstract

Pituitary tumor transforming gene 1 (PTTG1), recently cloned from human testis, is a potent oncogene that is expressed in most tumors. However, assessment of its potential value as a prognostic marker is dependent on the development of a suitable antibody. We have developed a rabbit polyclonal antibody, SK601, that is highly specific for the PTTG1 gene product using recombinant PTTG1 protein (24 kD) containing an N-terminal His(6) tag as the immunogen. The antiserum is capable of detecting recombinant PTTG1 protein in ELISA assays at a titer of 1:100,000. Use of the antibody as the probe in Western blotting analyses revealed a single band with the anticipated relative molecular weights of 52 kD from E. coli expressing the GST-PTTG1 recombinant protein, and 56 kD from COS-7 cells transfected with the PTTG1-GFP chimeric construct. A single band with a relative molecular weight of 28 kD was observed in extract of COS-7 cells transfected with PTTG1 cDNA. The antiserum immunoprecipitated a protein of relative molecular weight of 56 kD from the extracts of COS-7 cells transfected with the PTTG1-GFP chimeric construct. Immunohistochemical analysis of COS-7 cells transfected with this construct confirmed that the antibody detected and was specific for expressing the PTTG1-GFP recombinant protein. Screening of various normal human tissues (testis, ovary, and breast) by immunohistochemistry indicated that these tissues did not exhibit staining with the exception of testis, a tissue that had previously been shown to express PTTG1 mRNA. In contrast all of the tumor tissues (testicular tumor, ovarian tumor, and breast tumor) that were assessed exhibited intense staining. The results suggest that antiserum SK601 is highly specific for the PTTG1 protein and therefore should prove useful in further analysis of the expression and interactions of this protein, including its potential application as an immunohistochemical marker of human tumors.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11724901     DOI: 10.1177/002215540104901207

Source DB:  PubMed          Journal:  J Histochem Cytochem        ISSN: 0022-1554            Impact factor:   2.479


  8 in total

1.  Inhibition of PTTG1 expression by microRNA suppresses proliferation and induces apoptosis of malignant glioma cells.

Authors:  Xing Su; Jianguo Chen; Lanchun Ni; Wei Shi; Jinlong Shi; Xiaojiang Liu; Yu Zhang; Peipei Gong; Hui Zhu; Qingfeng Huang
Journal:  Oncol Lett       Date:  2016-08-22       Impact factor: 2.967

2.  Tumorigenic potential of pituitary tumor transforming gene (PTTG) in vivo investigated using a transgenic mouse model, and effects of cross breeding with p53 (+/-) transgenic mice.

Authors:  Miranda Y Fong; Hanan Farghaly; Sham S Kakar
Journal:  BMC Cancer       Date:  2012-11-20       Impact factor: 4.430

3.  PTTG1: a Unique Regulator of Stem/Cancer Stem Cells in the Ovary and Ovarian Cancer.

Authors:  Seema Parte; Irma Virant-Klun; Manish Patankar; Surinder K Batra; Alex Straughn; Sham S Kakar
Journal:  Stem Cell Rev Rep       Date:  2019-12       Impact factor: 6.692

4.  Regulation of angiogenesis and invasion by human Pituitary tumor transforming gene (PTTG) through increased expression and secretion of matrix metalloproteinase-2 (MMP-2).

Authors:  Mohammad T Malik; Sham S Kakar
Journal:  Mol Cancer       Date:  2006-11-10       Impact factor: 27.401

5.  Ectopic expression of PTTG1/securin promotes tumorigenesis in human embryonic kidney cells.

Authors:  Tariq Hamid; Mohammed T Malik; Sham S Kakar
Journal:  Mol Cancer       Date:  2005-01-13       Impact factor: 27.401

6.  Effect of PTTG on endogenous gene expression in HEK 293 cells.

Authors:  Siva K Panguluri; Sham S Kakar
Journal:  BMC Genomics       Date:  2009-12-03       Impact factor: 3.969

7.  PTTG: an important target gene for ovarian cancer therapy.

Authors:  Siva Kumar Panguluri; Casey Yeakel; Sham S Kakar
Journal:  J Ovarian Res       Date:  2008-10-20       Impact factor: 4.234

8.  PTTG/securin activates expression of p53 and modulates its function.

Authors:  Tariq Hamid; Sham S Kakar
Journal:  Mol Cancer       Date:  2004-07-08       Impact factor: 27.401

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.